Mark Herr, MD
Orthopaedic Surgery · Rochester, MNNPI 1477532711
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,317 of the $2,140 with a category attached, or 61.5%. 6 manufacturers reported payments, led by Gemini Medical LLC at 45.0% of the total. Reporting peaked in 2019 at $1,098 and has fallen 77.1% since, to $251 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in MN, where the typical reported total is $3,921.
Across 18 payments — averaging $118.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gemini Medical LLC$963
- Stryker$796
- Johnson & Johnson$202
- Medical Device Business Services, Inc.$125
- Zimmer Biomet$44
- Orthofix Medical, Inc.$10
What the payments were for
- Food & beverage$82438%
- Education$1,31762%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gemini Medical LLC | 1 | $963 |
| Stryker | 11 | $796 |
| Johnson & Johnson | 2 | $202 |
| Medical Device Business Services, Inc. | 1 | $125 |
| Zimmer Biomet | 2 | $44 |
| Orthofix Medical, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,140 in reported general payments places this provider in the 35th percentile of 533 orthopaedic surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 14 | $113 |
| Meloxicam | 40 | $105 |
| Methylprednisolone | 13 | $86 |
| Tramadol Hcl | 38 | $60 |
| Oxycodone Hcl | 19 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Rochester
- Daniel BerryRochester$21.5M
- Mark PagnanoRochester$14.8M
- Robert TrousdaleRochester$12.2M
- John SperlingRochester$12.2M
- Shawn O'DriscollRochester$10.5M
- David LewallenRochester$8M
- Rafael SierraRochester$4.9M
- Joaquin Sanchez-SoteloRochester$4M
- Michael TauntonRochester$3.5M
- Arlen HanssenRochester$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.